Keywords: Renvela, Impax. Watson, Genzyme, Serum phosphorous levels control, Patent, Generic filing, USA

Impax and Watson challenge Genzyme’s Renvela patent

Article | 05 July 2010

Print This

USA-based generic drugmaker Impax Laboratories has confirmed initiation of a challenge of a patent listed by Genzyme in connection with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in